322 results
Page 4 of 17
8-K
EX-99.1
ppu3ddu49oojei1 n7rx
16 Jul 20
Bristol Myers Squibb Announces Expiration and Final Results of Registered Exchange Offers
8:30am
8-K
EX-99.1
d3nq5w57
16 Jun 20
Bristol Myers Squibb Announces Commencement of Registered Exchange Offers
8:39am
424B3
xnshzv3ptppvbwa6059
16 Jun 20
Prospectus supplement
8:01am
8-K
EX-99.1
x45vmg
7 May 20
Bristol Myers Squibb Reports Strong First Quarter 2020 Financial Results
8:08am
DEFA14A
i5u83q8p
23 Apr 20
Additional proxy soliciting materials
8:59am
8-K
EX-99.1
vtrhwj98 t51d7hw
25 Mar 20
Other Events
9:15am
8-K
EX-99.1
59rfcn9zlmk
6 Feb 20
Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results for 2019
8:20am
8-K/A
EX-99.1
pqkcnady9ir8qnk wzmk
5 Feb 20
Report of Independent Registered Public Accounting Firm
4:42pm
8-K
EX-99.1
f9w2p
31 Oct 19
Bristol-Myers Squibb Reports Third Quarter Financial Results
8:01am
8-K
EX-99.1
ur4lvkh1rxhnshfh52
12 Sep 19
Bristol-Myers Squibb Board Announces Election of Three New Directors
5:27pm
8-K
bxr89k6n ib
12 Sep 19
Bristol-Myers Squibb Board Announces Election of Three New Directors
5:27pm
8-K
EX-99.1
s34ulnqws8pblhu5ehzw
26 Aug 19
Bristol-Myers Squibb Announces Agreement Between Celgene and Amgen to Divest OTEZLA® for $13.4 Billion
8:30am
8-K
EX-99.1
gg4ch
25 Jul 19
Bristol-Myers Squibb Reports Second Quarter Financial Results
8:21am
8-K
EX-99.1
5lx5 7tk2
5 Jun 19
Bristol-Myers Squibb Announces Post-Closing Leadership Team
8:24am
8-K
EX-99.1
eau8d16lm6puhy4xn
1 May 19
Other Events
8:30am